JCU Corporation (4975.T)
Tokyo, JP
Headquartered in Tokyo, Japan, JCU Corporation manufactures and supplies a range of chemicals, specialized machinery, and ancillary equipment for surface finishing applications. The company's chemical products serve purposes such as enhancing aesthetics and providing rust protection for items like automotive components, plumbing fixtures, and building materials. They are also indispensable in the production of printed circuit boards (PCBs), electronic components, and semiconductors. Furthermore, JCU Corporation provides automated plating and processing systems, as well as distinct etching and washing devices for PCBs, including vertical batch, panel-to-panel, and roll-to-roll variants. The company also undertakes the design, installation, and ongoing management of solar photovoltaic electricity generation sites. Founded in 1957, the firm was previously known as Ebara-Udylite Co., Ltd. before officially rebranding as JCU Corporation in October 2012.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.23% | +12.25% | +28.13% | +31.37% | +77.05% | +59.30% | +137.86% | +136.06% | +110.26% | +797.98% | +2,125.71% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+4.6% Q1'26: +7.0% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+22.8% ★ Q1'26: +25.6% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+41.0% ★ Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+41.0% ★ Q1'26: +40.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%—
-
Share dilution Chemicals - Specialty: +0.1%-1.5% ★ Q1'26: -1.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×— Q1'26: 0.03× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
19.80B
est: 19.75B (+0.3%)
|
19.82B
est: 19.55B (+1.4%)
|
20.76B
est: 20.50B (+1.3%)
|
23.12B
est: 22.65B (+2.1%)
|
24.87B
est: 25.25B (-1.5%)
|
22.32B
est: 22.50B (-0.8%)
|
21.19B
est: 21.75B (-2.6%)
|
24.26B
est: 24.33B (-0.3%)
|
27.14B
est: 27.00B (+0.5%)
|
24.86B
est: 25.55B (-2.7%)
|
28.36B
est: 28.00B (+1.3%)
|
29.15B
29.15B – 29.15B
+4.1% YoY
|
31.50B
31.50B – 31.50B
+8.1% YoY
|
34.25B
34.25B – 34.25B
+8.7% YoY
|
39.00B
39.00B – 39.00B
+13.9% YoY
|
| EBITDA |
5.12B
est: 7.52B (-31.9%)
|
5.44B
est: 7.44B (-26.9%)
|
6.08B
est: 7.80B (-22.0%)
|
7.54B
est: 8.62B (-12.5%)
|
7.66B
est: 9.61B (-20.3%)
|
6.88B
est: 8.56B (-19.6%)
|
7.46B
est: 8.28B (-9.9%)
|
9.61B
est: 9.26B (+3.8%)
|
9.97B
est: 10.28B (-3.0%)
|
8.83B
est: 10.94B (-19.3%)
|
11.38B
est: 11.99B (-5.1%)
|
12.48B
12.48B – 12.48B
+4.1% YoY
|
13.49B
13.49B – 13.49B
+8.1% YoY
|
14.67B
14.67B – 14.67B
+8.7% YoY
|
16.70B
16.70B – 16.70B
+13.9% YoY
|
| EBIT |
4.61B
est: 6.97B (-33.9%)
|
4.91B
est: 6.90B (-28.9%)
|
5.50B
est: 7.23B (-23.9%)
|
6.95B
est: 7.99B (-13.0%)
|
7.07B
est: 8.91B (-20.6%)
|
6.30B
est: 7.94B (-20.7%)
|
6.86B
est: 7.67B (-10.7%)
|
8.99B
est: 8.58B (+4.7%)
|
9.29B
est: 9.53B (-2.5%)
|
8.10B
est: 10.07B (-19.6%)
|
10.51B
est: 11.04B (-4.8%)
|
11.49B
11.49B – 11.49B
+4.1% YoY
|
12.42B
12.42B – 12.42B
+8.1% YoY
|
13.50B
13.50B – 13.50B
+8.7% YoY
|
15.37B
15.37B – 15.37B
+13.9% YoY
|
| Net Income |
3.20B
est: 2.95B (+8.8%)
|
3.41B
est: 3.04B (+12.1%)
|
4.12B
est: 3.51B (+17.5%)
|
4.91B
est: 4.45B (+10.3%)
|
4.96B
est: 4.25B (+16.8%)
|
4.42B
est: 4.28B (+3.2%)
|
4.71B
est: 4.34B (+8.6%)
|
6.37B
est: 5.70B (+11.8%)
|
6.01B
est: 6.26B (-3.9%)
|
5.53B
est: 6.04B (-8.4%)
|
7.50B
est: 7.27B (+3.2%)
|
8.70B
8.70B – 8.70B
+19.7% YoY
|
9.17B
9.17B – 9.17B
+5.4% YoY
|
10.25B
10.25B – 10.25B
+11.8% YoY
|
12.23B
12.23B – 12.23B
+19.3% YoY
|
| SGA |
5.59B
est: 4.91B (+13.8%)
|
5.73B
est: 4.86B (+17.8%)
|
5.37B
est: 5.10B (+5.3%)
|
5.72B
est: 5.64B (+1.6%)
|
5.77B
est: 6.28B (-8.1%)
|
5.71B
est: 5.60B (+2.0%)
|
5.06B
est: 5.41B (-6.6%)
|
5.38B
est: 6.05B (-11.1%)
|
5.65B
est: 6.72B (-15.9%)
|
5.56B
est: 5.67B (-2.1%)
|
6.18B
est: 6.22B (-0.5%)
|
6.47B
6.47B – 6.47B
+4.1% YoY
|
6.99B
6.99B – 6.99B
+8.1% YoY
|
7.60B
7.60B – 7.60B
+8.7% YoY
|
8.66B
8.66B – 8.66B
+13.9% YoY
|
| EPS |
113.58
est: 116.95 (-2.9%)
|
120.88
est: 120.84 (+0.0%)
|
147.56
est: 139.35 (+5.9%)
|
176.31
est: 176.60 (-0.2%)
|
178.55
est: 168.80 (+5.8%)
|
163.97
est: 169.90 (-3.5%)
|
178.34
est: 172.15 (+3.6%)
|
243.82
est: 226.27 (+7.8%)
|
232.63
est: 248.50 (-6.4%)
|
216.96
est: 239.75 (-9.5%)
|
297.72
est: 288.55 (+3.2%)
|
345.50
345.50 – 345.50
+19.7% YoY
|
364.05
364.05 – 364.05
+5.4% YoY
|
407.15
407.15 – 407.15
+11.8% YoY
|
485.80
485.80 – 485.80
+19.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-01 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Militia Long/Short Equity ETF ORR | 0.67% | 928.0K | 14.19% |
| 2 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.14% | 538.7K | 0.58% |
| 3 | iShares International Small-Cap Equity Factor ETF ISCF | 0.10% | 624.2K | 0.24% |
| 4 | State Street SPDR S&P International Small Cap ETF GWX | 0.09% | 748.3K | 0.40% |
| 5 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.06% | 363.3K | 0.58% |
| 6 | iShares $ Treasury Bond 3-7yr UCITS ETF CBUG.DE | 0.05% | 205.0K | 0.10% |
| 7 | WisdomTree Japan Hedged Equity Fund DXJ | 0.04% | 3.09M | 0.48% |
| 8 | iShares MSCI Japan Small-Cap ETF SCJ | 0.04% | 104.3K | 0.50% |
| 9 | Avantis International Small Cap Equity ETF AVDS | 0.04% | 126.5K | 0.30% |
| 10 | WisdomTree Japan Equity UCITS ETF DXJ.L | 0.04% | 305.4K | 0.48% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akihisa Ohmori | President, Chief Operating Officer & Representative Director | — | male |
| Fumihiko Araake | Managing Executive Officer, GM of Sales Headquarters & Director | — | male |
| Hideki Hagiwara | Executive Officer | — | — |
| Hirofumi Ikegawa | MD, Managing Executive Officer, GM of Administration Headquarters & Director | — | male |
| Masashi Kimura | Chief Executive Officer & Chairman | — | male |
| Takanori Arata | MD, Managing Executive Officer & Director | — | male |
| Toyokazu Imai | Executive Officer & Production Division Chief | — | — |
| Yoji Inoue | Managing Executive Officer, GM of Corporation Strategy Office & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4975.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
